Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FlexiCaps is a phytotherapy-based dietary supplement developed by Laboratoires Ortis to support joint health, flexibility, and comfort. The product is formulated with a combination of natural plant extracts, primarily harpagophytum (devil's claw), ash (frêne), and meadowsweet (reine des prés). The key active ingredients are harpagosides derived from harpagophytum, which are concentrated to provide anti-inflammatory action against joint pain and stiffness. Meadowsweet contributes natural salicylates, further supporting the reduction of inflammation. FlexiCaps is intended for oral administration and is available in capsule and tablet forms, offering a non-aggressive approach to maintaining joint mobility and addressing discomfort associated with joint wear.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on FlexiCaps.